We create custom, evidence-based HEOR solutions for value and access questions across a drug product life cycle, delivered with novel, elegant data visualizations.
We work with clients developing economic models and generate evidence as part of long-term strategic plans to demonstrate the value of medicines for engagement with HTA agencies, payers, academia, advocacy groups, and other stakeholders.
Our work addresses needs in early clinical development… through clinical trials…. to launch ….and patent expiry.
Health Economics
Leveraging clinical, epidemiological and economic data to create math-based intuitive models